EquityZen Growth Technology Fund LLC - Series 1778
Raised
$886K
Investors
17
Min Invest
$10,005
AltStreet Analysis
·Generated from EDGAR primary sources
EquityZen Growth Technology Fund LLC - Series 1778 is a Delaware pooled investment fund vehicle filed by EquityZen Advisors LLC and Philip Haslett on 2023-09-12. The fund raised $886K from 17 investors under Rule 506(b) and 3(c)(1) exemptions, with a $10K minimum investment. This is part of EquityZen's pre-IPO secondary platform, which operates over 1,800 series-based SPVs.
This pre-IPO vehicle uses the standard 506(b)/3(c)(1) exemption pairing common to secondary marketplace funds accessing private company shares. The $10K minimum investment positions it at the retail-accessible end of the pre-IPO category, significantly lower than the $100K–$250K minimums typical of institutional late-stage venture vehicles.
EDGAR Filing Data
Form D — Primary Source
View on SEC.govRelated Persons (Form D)
Executive officers, directors, and promoters listed on the SEC Form D filing. Source: SEC.gov.
Philip Haslett
Executive Officer, Director · New York, NY
EquityZen Advisors LLC
Executive Officer, Director · New York, NY
Is this your offering?
Claim this profile to add contact information, team members, LinkedIn profiles, fund history, and additional financial data. EDGAR-sourced data and AltStreet analysis cannot be edited, but corrections can be requested for verifiable inaccuracies.
Data Methodology
Capital raise figures, investor counts, and filing dates are sourced directly from SEC EDGAR Form D primary documents via the SEC EDGAR submissions API and full-text search index. EDGAR entity profiles and deal-level data are reviewed by AltStreet analysts with backgrounds in corporate finance and securities law — cross-referenced against offering circulars, audited financial statements, and primary regulatory filings before publication. Platform-provided information, where present, is clearly labeled and does not affect EDGAR data or AltStreet editorial coverage. Platforms may request factual corrections for demonstrable inaccuracies by contacting [email protected]. This page does not constitute investment advice.